• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活化部分凝血活酶时间和凝血酶原时间混合研究:最新进展。

Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art.

机构信息

Laboratory Corporation of America, Burlington, North Carolina.

Specialist Haemostasis Unit, Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.

出版信息

Semin Thromb Hemost. 2023 Sep;49(6):571-579. doi: 10.1055/s-0042-1756196. Epub 2022 Sep 2.

DOI:10.1055/s-0042-1756196
PMID:36055261
Abstract

Mixing studies have long been in the clinical laboratory armamentarium for investigating unexpected, prolonged activated partial thromboplastin time (aPTT) or prothrombin time (PT). The purpose of the mixing study is to identify whether the aPTT/PT prolongation is secondary to a factor deficiency versus an inhibitor, which would present as a "corrected" and "noncorrected" mixing study, respectively. The differentiation between a factor deficiency and inhibitor may likely further direct clinical decisions, including additional diagnostic testing or factor replacement therapy. While aPTT/PT mixing studies are simple tests to perform, there is a lack of standardization for both the testing protocol and the interpretation of what is considered to be a corrected or noncorrected mixing study result. This review will describe the common indications for the mixing test, preanalytic variables that may affect mixing study performance, and describe several methods for interpreting the results of aPTT and PT mixing tests.

摘要

混合研究长期以来一直是临床实验室的有力工具,用于研究意外的、延长的活化部分凝血活酶时间(aPTT)或凝血酶原时间(PT)。混合研究的目的是确定 aPTT/PT 延长是继发于因子缺乏还是抑制剂,分别表现为“纠正”和“未纠正”混合研究。因子缺乏和抑制剂之间的区别可能进一步指导临床决策,包括进一步的诊断测试或因子替代治疗。虽然 aPTT/PT 混合研究是简单的测试,但在测试方案和对被认为是纠正或未纠正混合研究结果的解释方面缺乏标准化。这篇综述将描述混合试验的常见适应证、可能影响混合研究结果的分析前变量,并描述几种解释 aPTT 和 PT 混合试验结果的方法。

相似文献

1
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art.活化部分凝血活酶时间和凝血酶原时间混合研究:最新进展。
Semin Thromb Hemost. 2023 Sep;49(6):571-579. doi: 10.1055/s-0042-1756196. Epub 2022 Sep 2.
2
Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time.混合研究在患有延长的活化部分凝血活酶时间或凝血酶原时间的患者中。
Anesth Analg. 2019 Jun;128(6):1089-1096. doi: 10.1213/ANE.0000000000003457.
3
A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting.单中心回顾性研究:门诊环境中凝血酶原时间和活化部分凝血活酶时间延长的原因。
Int J Lab Hematol. 2022 Feb;44(1):209-215. doi: 10.1111/ijlh.13727. Epub 2021 Oct 5.
4
International Council for Standardization in Haematology Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies.国际血液学标准化委员会现场研究评估活化部分凝血活酶时间和凝血酶原时间混合研究的最佳解释方法。
Arch Pathol Lab Med. 2024 Aug 1;148(8):880-889. doi: 10.5858/arpa.2023-0030-OA.
5
Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method.使用估计因子校正方法评估凝血酶原时间和活化部分凝血活酶时间混合试验。
Blood Coagul Fibrinolysis. 2016 Jan;27(1):90-6. doi: 10.1097/MBC.0000000000000375.
6
Interpreting coagulation mixing study results in the era of direct oral anticoagulants.在直接口服抗凝剂时代解读凝血混合试验结果。
Blood Coagul Fibrinolysis. 2024 Jan 1;35(1):23-26. doi: 10.1097/MBC.0000000000001267. Epub 2023 Nov 6.
7
On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery.现场凝血酶原时间、活化部分凝血活酶时间及血小板计数。心脏手术患者全血检测与实验室检测及凝血因子分析的比较。
Anesthesiology. 1994 Feb;80(2):338-51. doi: 10.1097/00000542-199402000-00014.
8
Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.凝血酶原时间和活化部分凝血活酶时间在诊断手术出血增加中的变异性。
Transfusion. 1999 Jan;39(1):56-62. doi: 10.1046/j.1537-2995.1999.39199116895.x.
9
Evaluation of Activated Partial Thromboplastin Time Mixing Studies Using Several Methods.采用多种方法评价活化部分凝血活酶时间混合研究。
Arch Pathol Lab Med. 2022 Nov 1;146(11):1387-1394. doi: 10.5858/arpa.2021-0123-OA.
10
Standardization of coagulation tests.凝血试验的标准化。
Southeast Asian J Trop Med Public Health. 1999;30 Suppl 3:79-85.

引用本文的文献

1
Progressive cephalohematoma in a neonate revealing severe hemophilia a owing to intron 22 inversion: a case report.新生儿进行性头颅血肿提示因内含子22倒位导致严重甲型血友病:一例报告
Front Pediatr. 2025 Jul 18;13:1649183. doi: 10.3389/fped.2025.1649183. eCollection 2025.
2
Nomogram for prediction of in-hospital mortality rate in children with congenital heart disease in pediatric intensive care: establishment and external validation.儿科重症监护中先天性心脏病患儿院内死亡率预测列线图:建立与外部验证
Transl Pediatr. 2025 Apr 30;14(4):533-544. doi: 10.21037/tp-2024-506. Epub 2025 Apr 27.
3
The evaluation of prothrombin time and activated partial thromboplastin time among diabetic and healthy controls in Africa: systematic review and meta-analysis.
非洲糖尿病患者与健康对照者的凝血酶原时间和活化部分凝血活酶时间评估:系统评价与荟萃分析
Front Med (Lausanne). 2024 Dec 6;11:1445031. doi: 10.3389/fmed.2024.1445031. eCollection 2024.
4
Laboratory and Molecular Diagnosis of Factor XI Deficiency.因子 XI 缺乏症的实验室及分子诊断
Semin Thromb Hemost. 2025 Mar;51(2):145-154. doi: 10.1055/s-0044-1792033. Epub 2024 Nov 4.
5
Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis.应用血栓波形分析检测肝细胞癌患者的前血栓状态。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296241246002. doi: 10.1177/10760296241246002.
6
[Chinese guidelines on the diagnosis and management of hemophilia with inhibitors (2023)].[中国血友病合并抑制物诊断与治疗指南(2023年版)]
Zhonghua Xue Ye Xue Za Zhi. 2023 Nov 14;44(11):881-889. doi: 10.3760/cma.j.issn.0253-2727.2023.11.001.
7
Diagnosis and laboratory monitoring of acquired hemophilia A.获得性血友病 A 的诊断和实验室监测。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):11-18. doi: 10.1182/hematology.2023000460.
8
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls.国际血液学标准化委员会关于凝血试剂、校准品和质控品新批号验证的指南。
Semin Thromb Hemost. 2024 Nov;50(8):1091-1102. doi: 10.1055/s-0043-1776405. Epub 2023 Nov 15.